Combination of VEGF siRNA and KSP siRNA in a ratio of 1:1. Size around 80 nm with the neutral charged at physiologic pH.Note: the first lipid nanoparticle-formulated siRNA therapeutic to be tested in cancer patients. Here, VEGFA is linked to cancer.